Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ignacio Sánchez-Moguel"'
Publikováno v:
Pathogens, Vol 12, Iss 8, p 1007 (2023)
Virus-like particles (VLPs) comprise one or many structural components of virions, except their genetic material. Thus, VLPs keep their structural properties of cellular recognition while being non-infectious. VLPs of Parvovirus B19 (B19V) can be pro
Externí odkaz:
https://doaj.org/article/241300a218b2405598d536a3002a084f
Autor:
David Rodrigues, Omar Pillaca-Pullo, Karin Torres-Obreque, Juan Flores-Santos, Ignacio Sánchez-Moguel, Marcela V. Pimenta, Tajindar Basi, Attilio Converti, André M. Lopes, Gisele Monteiro, Luís P. Fonseca, Adalberto Jr. Pessoa
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 7 (2019)
L-Asparaginase (ASNase) is used in the treatment of acute lymphoblastic leukemia, being produced and commercialized only from bacterial sources. Alternative Saccharomyces cerevisiae ASNase II coded by the ASP3 gene was biosynthesized by recombinant P
Externí odkaz:
https://doaj.org/article/74b7725e98844f49af2eef5923dcf8bc
Autor:
André Moreni Lopes, Tajindar Basi, Ignacio Sánchez-Moguel, Omar Pillaca-Pullo, Marcela Pimenta, Valker Araujo Feitosa, Michele Vitolo, Amparo I. Zavaleta, Gisele Monteiro, Adalberto Pessoa, David Rodrigues
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
BACKGROUND: l‐asparaginase (ASNase), a biopharmaceutical enzyme used in the treatment of childhood lymphoid malignancies, is commercially produced from Escherichia coli and Erwinia chrysanthemi. However, it causes severe adverse effects due to alle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a1a7b9b8f552ff7cb33a87d0d06762
Autor:
Rominne Karla Barros, Freire, Carlos Miguel Nóbrega, Mendonça, Rafael Bertelli, Ferraro, Ignacio Sánchez, Moguel, Aldo, Tonso, Felipe Rebello, Lourenço, João Henrique Picado Madalena, Santos, Lara Durães, Sette, Adalberto, Pessoa Junior
Publikováno v:
Preparative biochemistrybiotechnology. 51(3)
L-asparaginase (ASNase) is an essential drug in the treatment of acute lymphoblastic leukemia (ALL). Commercial bacterial ASNases increase patient survival, but the consequent immunological reactions remain a challenge. Yeasts ASNase is closer to hum
Autor:
Tajindar Basi, Juan Carlos Flores-Santos, Omar Pillaca-Pullo, Marcela V. Pimenta, David Rodrigues, Luís P. Fonseca, Gisele Monteiro, Karin Torres-Obreque, Ignacio Sánchez-Moguel, André Moreni Lopes, Adalberto Pessoa, Attilio Converti
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 7 (2019)
Frontiers in Bioengineering and Biotechnology
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Frontiers in Bioengineering and Biotechnology
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
L-Asparaginase (ASNase) is used in the treatment of acute lymphoblastic leukemia, being produced and commercialized only from bacterial sources. Alternative Saccharomyces cerevisiae ASNase II coded by the ASP3 gene was biosynthesized by recombinant P
Autor:
Gisele Monteiro, Giuseppe Palmisano, Iris Munhoz Costa, Adalberto Pessoa, Brian Effer, Eduardo Krebs Kleingesinds, Veronica Feijoli Santiago, Guilherme Meira Lima, Jorge G. Farías, Ignacio Sánchez-Moguel
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
L-asparaginase (L-ASNase) is an important bacterial enzyme used as a biopharmaceutical to treat acute lymphoblastic leukemia (ALL). Side effects of L–ASNase therapy have been counteracted by polyethylene glycol (PEG)-modification of L-ASNase; howev
Autor:
Ignacio Sánchez Moguel
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
The L-asparaginase (ASNase) obtained from yeasts species has been poorly studied and a new yeast ASNase could be an alternative to minimize the side effect in the treatment of lymphoblastic leukemia. The Antarctic ecosystems have a great potential to
Autor:
Ignacio Sánchez Moguel
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USP
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
The L-asparaginase (ASNase) obtained from yeasts species has been poorly studied and a new yeast ASNase could be an alternative to minimize the side effect in the treatment of lymphoblastic leukemia. The Antarctic ecosystems have a great potential to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d01231d99bf54e8acdb0bb5e1db0f5